Immuron (IMRN) Net Income (2016 - 2024)
Immuron (IMRN) posted quarterly Net Income of $1792956885.9 billion for Q4 2024, up 86483332670285.19% year-on-year from N/an in Q1 2024, and up 86483332670285.19% on a QoQ basis from -$2.1 million in Q4 2023.
Immuron (IMRN) Net Income (2016 - 2024) Analysis & Trends
Immuron (IMRN) has reported Net Income for 9 consecutive years, with $1792956885.9 billion the latest figure, recorded in Q4 2024.
- Quarterly Net Income rose 86483332670285.19% year-over-year to $1792956885.9 billion in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $1792956885.9 billion (up 86483332670285.23% YoY) and the FY2025 annual result came in at -$3.7 million, up 24.79% from the prior year.
- Net Income climbed to $1792956885.9 billion in Q4 2024 per IMRN's latest filing, from -$2.1 million in the prior quarter.
- Over the last five years, Net Income for IMRN reached as high as $1792956885.9 billion in Q4 2024 and fell as low as -$5.9 million in Q2 2021.
- A 5-year average of $199217431.8 billion and a median of -$2.0 million in 2022 frame the typical range for Net Income.
- Annual changes were most pronounced in 2022 — Net Income tumbled 2861.53% — and 2024, when it soared 86483332670285.19%.
- Year by year, Net Income stood at -$57387.7 in 2020, then soared by 77.71% to -$12792.9 in 2021, then slumped by 2861.53% to -$378866.2 in 2022, then slumped by 447.21% to -$2.1 million in 2023, then surged by 86483332670285.19% to $1792956885.9 billion in 2024.
- According to Business Quant data, Net Income over the past three periods registered $1792956885.9 billion, -$2.1 million, and -$2.7 million for Q4 2024, Q4 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,792,956,885.92 Bn |
| Dec 31, 2023 | -2.07 Mn |
| Jun 30, 2023 | -2.67 Mn |
| Dec 31, 2022 | -378,866.23 |
| Jun 30, 2022 | -2.02 Mn |
| Dec 31, 2021 | -12,792.94 |
| Jun 30, 2021 | -5.92 Mn |
| Dec 31, 2020 | -57,387.72 |
| Jun 30, 2020 | -2.07 Mn |
| Dec 31, 2019 | -15,212.27 |
| Dec 31, 2018 | -1.58 Mn |
| Dec 31, 2017 | -1.89 Mn |
| Dec 31, 2016 | -3.45 Mn |
| Jun 30, 2016 | -4.39 Mn |